
Our pick · Oct 2026
Embody
from $49/mo
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
- LegitScript certified
Our pick is a commercial choice. We may earn a commission when you join.
Does AHCCCS fee-for-service cover GLP-1s for weight loss?
If you are an adult and weight loss is your only reason, AHCCCS fee-for-service does not cover a GLP-1.
If one of the uses below applies to you, your prescriber can ask AHCCCS fee-for-service to cover that drug. Read the rule and its criteria.
Which drugs AHCCCS fee-for-service covers, and for what:
We checked 2 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.
8 programs that serve Arizona publish a complete monthly price, from $49 at Embody to $299 at Willow.

Our pick · Oct 2026
from $49/mo
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Our pick is a commercial choice. We may earn a commission when you join.
Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

Compounded semaglutide · 12-mo prepay
$588 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
$588 upfront for 12 months of semaglutide. Yearly-plan sale ends December 1; confirm renewal. Paid terms are normally non-refundable; provider-determined medical disqualification allows a refund for the unused term, less services already provided.
The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.
We checked this price on Oct 27, 2026.
Full review and sources
12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Fair: 7.3/10 · Compounded
Checked Jul 18, 2026; few independent reviews yet.
$1,188 paid once for the 12-month semaglutide plan; does not renew. Separate monthly subscription: $99 first, then $165. Confirm how four-week vial supplies cover the billing term.
12-month semaglutide one-time plan: $1,188 paid up front, with no renewal. Separate monthly Subscribe and Save is $99 for the first month, then $165. Product pages describe four-week vials; confirm supply coverage across the selected billing term.
We checked this price on Sep 3, 2026.
Full review and sources
Compounded semaglutide · 12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Good: 7.8/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
12-month compounded semaglutide plan: $1,188 billed every 12 months. The shortest plan is $149 every 4 weeks; plans renew until cancelled Compounded Semaglutide (12-month plan): $99 monthly equivalent; $1,188 billed every 12 months. Provider review, medication and shipping included; prescription required; treatment only if clinically appropriate. Checked October 5, 2026. Consultation: included. Shipping: free. The $99/mo semaglutide rate requires $1,188 upfront for 12 months; the shorter $149 plan bills every 4 weeks, not once per calendar month
We checked this price on Oct 5, 2026.
Full review and sources
Compounded semaglutide lozenge · auto-refill
Advertised program price, not an insurance copay.
Fair: 6.5/10 · Compounded
Checked Oct 16, 2026.
as low as, auto-refill
We checked this price on Oct 2, 2026.
Full review and sources$99/mo equivalent at Trimi Health
12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Jul 2, 2026.
$1,188 upfront for 12 months; applicable taxes may add to the bill 12-month prepay: $1,188 upfront ($99 monthly equivalent); does not auto-renew. The separate month-to-month semaglutide plan is $175
We checked this price on Oct 20, 2026.
Full review and sources$212/4 weeks equivalent at Enhance MD

48-week prepay
Advertised program price, not an insurance copay.
Excellent: 9.4/10 · Compounded
Checked Oct 16, 2026; some details not published.
Semaglutide 12-month plan rate, billed every 48 weeks. Shortest plan: $249 every 4 weeks. Confirm the upfront total and any discount.
$212 advertised four-week equivalent on the prepaid 48-week plan, not a calendar-year subscription; shortest plan is $249 billed every 4 weeks
We checked this price on Aug 28, 2026.
Full review and sourcesfrom$297/mo at Direct Meds GLP-1

Confirm the full bill
Advertised program price, not an insurance copay.
Good: 7.5/10 · Compounded
Checked Oct 16, 2026.
Confirm the current prescribed treatment and full bill with the provider.
We checked this price on Sep 3, 2026.
Full review and sourcesConfirm the full bill
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
$299/mo is a starting program price, not one rate for every product. Willow's current help center pricing article lists compounded semaglutide injections at $299/mo up to 3.5 mg and $399/mo at 7 mg, tirzepatide injections at $399/mo through 6.375 mg then $499/mo at 8.5 and 11 mg, $524/mo at 13.5 mg and $549/mo at 17 mg, semaglutide tablets at $299/mo for all listed dosages, and tirzepatide tablets at $399/mo at 6 and 10 mg and $459/mo at 20 mg. Public price schedule checked September 26, 2026; confirm the prescribed product and current quote. Compounded Semaglutide (injectable): Covers medication, consultations, shipping and dose adjustments. $299/mo holds to 3.5 mg, then $399/mo at 7 mg on the help center pricing article, verified 2026-09-03 Compounded Semaglutide (oral tablet, daily): Compounded daily dissolving tablet, $299/mo for all listed dosages in Willow's current help center price schedule. This is distinct from the injection's dose ladder and is not FDA-approved Wegovy. Price checked September 26, 2026. Consultation: included. Shipping: free. The reviewed catalogue lists compounded products; a current brand-name Wegovy or Zepbound offer did not appear there
We checked this price on Sep 26, 2026.
Full review and sources3 more programs serve Arizona without one complete monthly price: Collective, Maximus and Wellorithm. Compare their terms in the price index.
We left out 29 programs whose service-area list has a caveat for Arizona or is incomplete, so confirm your address at intake.
A program that serves Arizona still decides whether to prescribe. Before enrolling, confirm whether it accepts your Medicaid plan and whether your prescribed treatment is covered. The advertised cash prices are not insurance copays. Most listed programs sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.
Here is our summary of the AHCCCS fee-for-service rules we checked, with their criteria and limits.
The AHCCCS fee-for-service prior-authorization criteria effective October 1, 2026 describe indication-specific Wegovy pathways, not general adult weight-loss coverage. Confirm whether your insurance uses this fee-for-service guidance or a managed-care policy before applying these rules. Since February 1, 2026, the Wegovy criteria have treated weight-loss use of the injection and the tablet as a benefit exclusion, and AHCCCS does not cover other GLP-1 medicines prescribed only for weight loss. Your prescriber can request Wegovy injection or tablet to lower your heart attack and stroke risk if you are 45 or older, have a BMI of 30 or more and established heart disease, and do not have diabetes. Your prescriber can also request the injection if you have noncirrhotic MASH, a fatty liver disease, with stage F2 or F3 scarring. The AHCCCS criteria tell reviewers to deny Zepbound for obstructive sleep apnea as an obesity-related plan exclusion. AHCCCS handles diabetes drugs such as Mounjaro and Trulicity under separate type 2 diabetes rules. Ask your AHCCCS health plan which criteria apply to your exact drug and diagnosis; your plan reviews every request through prior authorization.
A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.
We checked AHCCCS fee-for-service prior authorization criteria, effective October 1, 2026: Wegovy guideline on October 15, 2026.
We checked AHCCCS fee-for-service prior authorization criteria, effective October 1, 2026: GLP-1 agonist guideline (Zepbound for sleep apnea listed as a plan exclusion) on October 15, 2026.
An older weight-loss pill is not an automatic coverage workaround in AHCCCS fee-for-service. AHCCCS's linked pharmacy manual lists medicines used for weight-loss treatment among its outpatient pharmacy exclusions. That is a general FFS rule about the purpose of treatment, not a determination of your eligibility for a specific medicine.
The same manual says its drug lists are not exhaustive: a nonlisted medicine that is otherwise eligible for reimbursement may be reviewed through prior authorization. That does not by itself override a weight-loss-use exclusion. Ask your prescriber or plan to check the exact medicine, condition being treated, age and benefit. Managed-care members should use their own plan's rules; the FFS formulary is not their coverage guide.
We checked AHCCCS FFS Provider Billing Manual, Chapter 12 Pharmacy Services, revised March 11, 2024 (linked individual chapter; pharmacy exclusions and nonlisted-drug rules) on November 4, 2026.
We checked AHCCCS FFS formulary directory: FFS versus health-plan applicability on November 4, 2026.
We checked AHCCCS FFS manual directory: use individual chapters while the master PDF is revised on November 4, 2026.
Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.
Before you pay cash, confirm:
An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.
Your prescriber sends AHCCCS fee-for-service a request with the records that show you meet the rule for your drug and diagnosis, and AHCCCS fee-for-service decides.
What your prescriber usually sends:
Your prescriber works from these AHCCCS fee-for-service documents:
Your prescriber's office files the request; you cannot file it yourself. If AHCCCS fee-for-service says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.
Medicare's GLP-1 Bridge follows federal rules in every state, so AHCCCS fee-for-service's policy does not decide your Medicare benefit.
We checked CMS's Bridge guidance for Part D plans on September 26, 2026.
Two free official services can help you, and we earn no commission from either.
The AHCCCS fee-for-service prior-authorization criteria effective October 1, 2026 describe indication-specific Wegovy pathways, not general adult weight-loss coverage.
Confirm whether your insurance uses this fee-for-service guidance or a managed-care policy before applying these rules. Since February 1, 2026, the Wegovy criteria have treated weight-loss use of the injection and the tablet as a benefit exclusion, and AHCCCS does not cover other GLP-1 medicines prescribed only for weight loss. Your prescriber can request Wegovy injection or tablet to lower your heart attack and stroke risk if you are 45 or older, have a BMI of 30 or more and established heart disease, and do not have diabetes. Your prescriber can also request the injection if you have noncirrhotic MASH, a fatty liver disease, with stage F2 or F3 scarring. The AHCCCS criteria tell reviewers to deny Zepbound for obstructive sleep apnea as an obesity-related plan exclusion. AHCCCS handles diabetes drugs such as Mounjaro and Trulicity under separate type 2 diabetes rules. Ask your AHCCCS health plan which criteria apply to your exact drug and diagnosis; your plan reviews every request through prior authorization. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.
Yes.
Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not AHCCCS fee-for-service's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.
Yes, from 11 online programs that publish a service area including Arizona.
At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.
Among programs that serve Arizona, the lowest complete monthly price we found is $49 at Embody.
Across the 10 compounded programs we track nationally, the median advertised recurring price is $124/mo, from $49 to $299. That national figure is not a measured Arizona average, insurance copay or quote for your dose.
Affiliate partners we feature. We may earn a commission.
Check the medication, commitment and total price for your selected plan.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.